What should be the primary target of "treat to target" in psoriatic arthritis?

What should be the primary target of "treat to target" in psoriatic arthritis?

<h4>Background</h4> <p>Treat to Target in psoriatic arthritis (PsA) recommendations have stated that the target should be remission or inactive disease. Potential definitions include Very Low Disease Activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Act...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Coates, LC, Lubrano, E, Perrotta, FM, Emery, P, Conaghan, PG, Helliwell, PS
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Journal of Rheumatology 2018

समान संसाधन

What should be the primary target of ‘treat to target’ in PsA?
द्वारा: Coates, L, और अन्य
प्रकाशित: (2018)

Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
द्वारा: Coates, L, और अन्य
प्रकाशित: (2022)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
द्वारा: Coates, L, और अन्य
प्रकाशित: (2019)

Sustained very low disease activity and remission in psoriatic arthritis patients
द्वारा: Lubrano, E, और अन्य
प्रकाशित: (2019)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
द्वारा: Lubrano E, और अन्य
प्रकाशित: (2016-10-01)

New approved drugs for psoriatic arthritis
द्वारा: F.M. Perrotta, और अन्य
प्रकाशित: (2016-09-01)

Precision medicine in psoriatic arthritis: how should we select targeted therapies?
द्वारा: Al-Mossawi, H, और अन्य
प्रकाशित: (2019)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
द्वारा: Ennio Lubrano, और अन्य
प्रकाशित: (2019-08-01)

How should we define disease and outcomes in axial psoriatic arthritis?
द्वारा: Coates, LC
प्रकाशित: (2021)

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
द्वारा: Ennio Lubrano, और अन्य
प्रकाशित: (2023-07-01)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
द्वारा: P.S. Helliwell
प्रकाशित: (2011-09-01)

The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.
द्वारा: Coates, L, और अन्य
प्रकाशित: (2017)

Does treat to target or achieving remission improve radiographic outcome in psa?
द्वारा: Coates, L, और अन्य
प्रकाशित: (2016)

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores
द्वारा: Weinstein, SM, और अन्य
प्रकाशित: (2021)

Novel concepts in psoriatic arthritis management: Can we treat to target?
द्वारा: Tucker, L, और अन्य
प्रकाशित: (2018)

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
द्वारा: Dures, E, और अन्य
प्रकाशित: (2020)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
द्वारा: Ye, W, और अन्य
प्रकाशित: (2021)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
द्वारा: Gladman, DD, और अन्य
प्रकाशित: (2022)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
द्वारा: Helliwell, PS, और अन्य
प्रकाशित: (2023)

Assessment of patient-physician interactions in psoriatic arthritis: national results of the ASSIST Study
द्वारा: Perrotta, FM, और अन्य
प्रकाशित: (2024)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
द्वारा: Ye, W, और अन्य
प्रकाशित: (2021)

Occult axial involvement in patients with psoriatic arthritis mutilans: a case report
द्वारा: F.M. Perrotta, और अन्य
प्रकाशित: (2019-07-01)

Current concepts and unmet needs in psoriatic arthritis
द्वारा: Mahmood, F, और अन्य
प्रकाशित: (2017)

Psoriatic arthritis: prospects for the future
द्वारा: Hackett, S, और अन्य
प्रकाशित: (2022)

Should methotrexate have any place in the treatment of psoriatic arthritis?
द्वारा: Ye, W, और अन्य
प्रकाशित: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
द्वारा: Helliwell, PS, और अन्य
प्रकाशित: (2021)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
द्वारा: Coates, L, और अन्य
प्रकाशित: (2016)

Measuring outcomes in psoriatic arthritis
द्वारा: Ogdie, A, और अन्य
प्रकाशित: (2020)

Outcome measures in psoriatic arthritis: where next?
द्वारा: Hackett, S, और अन्य
प्रकाशित: (2022)

Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
द्वारा: Ennio Lubrano, और अन्य
प्रकाशित: (2022-12-01)

Psoriatic arthritis: lessons from imaging studies and implications for therapy
द्वारा: Mathew, A, और अन्य
प्रकाशित: (2016)

Assessing disease activity in psoriatic arthritis: a literature review
द्वारा: Tucker, L, और अन्य
प्रकाशित: (2018)

Treatment to target in psoriatic arthritis with apremilast: probability of achieving targets and comprehensive control of disease manifestations
द्वारा: Mease, PJ, और अन्य
प्रकाशित: (2020)

Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial
द्वारा: Helliwell, P, और अन्य
प्रकाशित: (2019)

Cost-effectiveness of tight control of inflammation in early psoriatic arthritis: economic analysis of a multicenter randomized controlled trial
द्वारा: O'Dwyer, J, और अन्य
प्रकाशित: (2018)

Remission in psoriatic arthritis—where are we now?
द्वारा: Coates, L, और अन्य
प्रकाशित: (2017)

Identification of psoriatic arthritis in patients with psoriasis
द्वारा: Coates, LC, और अन्य
प्रकाशित: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
द्वारा: Soriano, ER, और अन्य
प्रकाशित: (2023)

Psoriatic arthritis: imaging techniques
द्वारा: E. Lubrano, और अन्य
प्रकाशित: (2012-06-01)

Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
द्वारा: Coates, L, और अन्य
प्रकाशित: (2018)